Genomic Variant Analysis &Clinical Interpretation

Genomic Variant Analysis & Clinical Interpretation is a 16 module online course providing hands-on exposure to analysis and clinical interpretation of genomic variants.

The GVACI 2022 Course has started. Please login to the Learning Portal to access the course. No emails would be sent.

Special Registration for Students

Registrations are open until 31st May 2022 for undergraduate and postgraduate students in life sciences

If you do not have a GVACI portal login yet, please re-register yourself using the link, even if you have registered previously

The GVACI 2022

Course

IN NUMBERS

1700+

Registrants

40+

Countries represented

16

Learning Modules

10+

Faculty

Course Overview

While genomics is increasingly being applied in clinical settings for diagnosis, prognosis and precise management of diseases, there is a dearth of expertise and knowledgebase to adequately interpret evidence on genetic variants to impact healthcare decisions.

This course provides an overview of the concepts and methods of genomic variant analysis and clinical interpretation.

Faculty

Aastha V
Vigneshwar Senthilvel
Arushi Batra
Srashti Jyoti Agrawal
Mukta Poojary
Mohamed Imran
Anjali Bajaj
Vishu Gupta
Abhinav Jain
Bani Jolly

Who can attend ?

Clinicians, Clinical Geneticists and Genetic Counsellors, Undergraduate and postgraduate Medical Students, Nurses and Nursing Students. Faculty members in medical teaching and research organizations

What will I learn ?

You are expected to learn about the basic concepts of genetics and genomics, variant nomenclature and tools for variant analysis as well as their clinical interpretation. The course would follow the Standards and guidelines for the interpretation of sequence variants as per the joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP). Individuals who clear the course are expected to be well versed with the basic concepts of genomics as well as approaches to independently evaluate evidence and interpret the pathogenicity of genetic variants.

Genomics of Rare Diseases in India

Genomics for Understanding Rare Diseases India Alliance Network (GUaRDIAN) is a consortium of over 300 clinicians and researchers from over 70 medical and research centers making it one of the largest clinical genomics research networks in India for Rare Genetic Diseases.

The programme is funded by CSIR India. Learn more

Read more about the programme in the recent overview Genomics of rare genetic diseases—experiences from India Human Genomics 13:52 (2019)
This educational initiative has been organised as part of the educational outreach of GUaRDIAN.

The CSIR-IGIB Sanofi Genzyme Fellowship in Genomics for Medical Professionals aims to introduce fundamental aspects of genomics and molecular medicine to clinicians through short-term visit, interaction and hands-on training on specific aspects of genomics with the faculty at the CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB) in Delhi.

This fellowship programme was made possible with an unrestricted educational grant from Sanofi Genzyme. The funders have no role in the creation of content, selection of participants or administration of the course.